Owner Scorecard


← All companies ← INDI Manual INGM → ← INCR Pharmaceuticals INSM →

INDV, Indivior Pharmaceuticals Inc.

Pharmaceuticals consumer brand

A pharmaceutical business, where patents grant a temporary monopoly the pipeline must keep refilling.

Latest annual: FY2025 10-K
INDV · Indivior Pharmaceuticals Inc.
I

The business

What it sells, where the money comes from, the kind of company it is.

Revenue · FY2025
$1.2B
+4.3% YoY · 11% 3-yr CAGR
Vital signs · TTM, with 4-yr average
Revenue $1.3B 4-yr avg $1.1B
Gross margin 82% 4-yr avg 82%
Operating margin 31.6% 4-yr avg 0.4%
Owner-earnings margin −4% 4-yr avg −8%
Free cash flow margin −8% 4-yr avg −9%

Next report Est. 10/27–11/4 · the 10-Q for the quarter ended late September · due within 40 days of period end · has filed ~31 days after · the wire records it on arrival

The business in brief

read the 10-K →

What this business is and what moves its needle, from its own SEC filings.

What moves the needle
Operating margin has reached 21% at its best but run negative through the cycle (median −2.9%) on a 82% gross margin — so the question is which reading is truer: whether the median was pulled below zero by one-off charges, by the cycle, or by spending it is still growing into, and whether it settles back at a profit. Inventory runs near 12% of sales, so how fast it turns back into cash — and the risk of writing it down when demand softens — sits alongside the margin. Read this kind of business on the pipeline against the patent cliff, and pricing. On its own account, the filing leans hardest on pricing power & competition, set against the numbers in what the filing emphasizes, below.

Every line is arithmetic on the company's filings, shown in full in the sections below.

II

The record

Ten years of arithmetic, read across the cycle.

The record, 2022–2025

realized figures from each filing · older years to the left
2022’222023’232024’242025’25TTMTTMJun 2026
Income statement
$901M$1.1B$1.2B$1.2B$1.3BRevenueRevenue
$749M$919M$957M$994M$1.1BGross profitGross prof.
83%84%81%80%82%Gross marginGross mgn
52%52%52%51%44%SG&A / revenueSG&A/rev
8%11%9%8%6%R&D / revenueR&D/rev
($81M)($152M)$38M$262M$421MOperating incomeOp. inc.
−9.0%−13.9%3.2%21.1%31.6%Operating marginOp. mgn
($89M)($145M)$20M$239MPretax incomePretax
($44M)($126M)$7M$210M$356MNet incomeNet inc.
12%10%Effective tax rateTax rate
Cash flow & returns
($4M)($300M)$36M($27M)($40M)Operating cash flowOp. cash
$16M$15M$16M$10M$9MDepreciation & amortizationD&A
$8M($210M)($11M)($273M)($437M)Working capital & otherWC & other
$5M$8M$29M$66M$71MCapexCapex
0.6%0.7%2.4%5.3%5.3%Capex / revenueCapex/rev
($9M)($308M)$20M($37M)($49M)Owner earningsOwner earn.
−1.0%−28.2%1.7%−3.0%−3.7%Owner earnings marginOE mgn
($9M)($308M)$7M($93M)($111M)Free cash flowFCF
−1.0%−28.2%0.6%−7.5%−8.3%Free cash flow marginFCF mgn
$0$129M$0$0$0AcquisitionsAcquis.
$90M$33M$173M$11MBuybacksBuybacks
($222M)($95M)$69M($66M)Investing cash flowInv. cash
($101M)($64M)($102M)($30M)Financing cash flowFin. cash
($1M)$1M$0($1M)Exchange-rate effectFX
($328M)($458M)$3MChange in cashΔ cash
Balance sheet
$774M$410M$320M$195M$222MCash & investmentsCash+inv
$254M$254M$253M$271MReceivablesReceiv.
$126M$167M$153M$150MInventoryInvent.
$39M$63M$48M$30MAccounts payablePayables
$341M$358M$358M$391MOperating working capitalOper. WC
$1.3B$827M$652M$725MCurrent assetsCur. assets
$1.3B$924M$914M$868MCurrent liabilitiesCur. liab.
1.0×0.9×0.7×0.8×Current ratioCurr. ratio
$84M$100M$144MNet PP&ENet PP&E
$5M$2M$2M$2MGoodwillGoodwill
$1.8B$1.3B$1.2B$1.2BTotal assetsAssets
$240M$333M$319M$487MTotal debtDebt
($170M)$13M$124M$265MNet debt / (cash)Net debt
-3.0×-4.3×0.9×5.8×15.6×Interest coverageInt. cov.
$1.9B$1.7B$1.3BTotal liabilitiesTotal liab.
($15M)($184M)($337M)($98M)($208M)Shareholders’ equityEquity
1.8%1.9%2.0%2.1%2.4%Stock comp / revenueSBC/rev
Per share
139M137M133M128M127MShares out (diluted)Shares
$6.48$7.98$8.93$9.68$10.48Revenue / shareRev/sh
$-0.32$-0.92$0.05$1.64$2.80EPS (diluted)EPS
$-0.06$-2.25$0.15$-0.29$-0.39Owner earnings / shareOE/sh
$-0.06$-2.25$0.05$-0.73$-0.87Free cash flow / shareFCF/sh
$0.04$0.06$0.22$0.52$0.56Cap. spending / shareCapex/sh
$-0.11$-1.34$-2.53$-0.77$-1.64Book value / shareBVPS
Per-share growththe realized rate an owner's share compounded
3-yr5-yr
Revenue / share+14.3%/yr+14.3%/yr (3-yr)
Capital spending / share+142.9%/yr+142.9%/yr (3-yr)

Net income is the accountant's number; owner earnings is the cash an owner could take out. The walk between them, off the cash-flow statement, and whether the gap is widening or holding.

In fiscal 2025 the business earned ($37M) of owner earnings, the operating cash left after the $10M it takes just to hold its position. It put $56M more into growth; free cash flow, after that spending, was ($93M).

FY2025FY2024FY2023FY2022
Reported net income$210M$7M($126M)($44M)
Depreciation & amortizationnon-cash charge added back+$10M+$16M+$15M+$16M
Stock-based compensationreal costnon-cash, but a real cost+$26M+$24M+$21M+$16M
Working capital & othertiming of cash in and out, other non-cash items−$273M−$11M−$210M+$8M
Cash from operations($27M)$36M($300M)($4M)
Maintenance capital expenditurethe spending needed just to hold position and volume−$10M−$16M−$8M−$5M
Owner earnings($37M)$20M($308M)($9M)
Growth capital expenditurediscretionary; spent to get bigger, not to stand still−$56M−$13M
Free cash flow($93M)$7M($308M)($9M)
Owner-earnings marginowner earnings ÷ revenue-3%2%-28%-1%

Owner earnings is the cash an owner could pull out without starving the business: operating cash less the maintenance capital it must spend to hold its position (here about $10M, roughly its depreciation, the rate its assets wear out). The other $56M of its capital spending is growth it chose, not upkeep it owed; charged only with the maintenance it must do, the business earns well more than the year's free cash flow shows. The cash-flow statement also adds stock comp back as non-cash, but it is a real cost paid in shares; counted as the expense it is (less $26M), owner earnings is nearer ($63M).

Much of fiscal 2025's profit didn't arrive as operating cash; it sits in “working capital & other” above. That can be a real inventory or timing swing, or profit that doesn't run through operating cash at all: a heavy tax year, equity-method earnings, or investment income booked through investing. For a year like this, owner earnings understates the cash earned; the full cash-flow statement carries the rest.

Maintenance capex is estimated as depreciation where a growing business invests above it; free cash flow is the figure the scorecard's free-cash margin reads.

III

Quality & stewardship

Returns, the balance sheet, capital allocation, and pay.

Owner’s Scorecard

FY2025 10-K · source on SEC EDGAR →

Will it survive?

  • Comfortable
    Operating income $262M ÷ interest expense $45M
    What this means

    Operating profit covers interest with the kind of margin Graham wanted for a defensive holding. Necessary, not sufficient, it says solvent, not cheap.

  • How heavy is the debt, net of cash? $124M · 0.5× operating profit
    Modest net debt
    Cash $195M − debt $319M
    What this means

    Netting $195M of cash and short-term investments against $319M of debt leaves $124M owed, about 0.5× a year's operating profit (1.2× on the gross debt, before the cash). Net debt is the leverage figure that matters: the cash is already set against the debt. Strategic or illiquid investments aren't counted here.

  • Long (60+ days)
    DSO 75 + DIO 227 − DPO 71 days
    What this means

    Days cash is tied up between paying suppliers and collecting from customers. Lower is better; a long cycle means growth itself eats cash.

Is it a good business?

  • Not enough data
    Industry peers: median -7%
    What this means

    The filing data didn't include the inputs for this check.

  • Consumes cash through the cycle
    4-yr median margin, range -28%–2%; latest ($37M) = operating cash ($27M) − maintenance capex $10M
    Industry peers: median -1%
    What this means

    What an owner could take out without starving the business: operating cash less the maintenance capital it must spend to hold its position — Buffett's owner earnings. That's -3% of revenue this year, a -2% median across 4 years. It chose to put $56M more into growth, so free cash flow this year was ($93M) — the gap is investment, not weakness. Treating stock comp as the real expense it is (less $26M of SBC) leaves ($63M).

  • Thinly cash-backed
    Cash from ops ($27M) ÷ net income $210M

    In the filing’s words Read against the cash, reported earnings have run ahead of the operating cash the business generated over the record — about 10% of assets a year, among the widest gaps in the catalogue, and a manipulation screen of eight balance-sheet ratios trips here too. For an inventory- or content-heavy grower that can be cash tied up in real assets as it expands; elsewhere it can mean the earnings lean on accounting estimates — the cash-flow statement against the income statement is where to tell which.

    What this means

    How much of reported profit showed up as operating cash. Above 1× is reassuring; well below suggests earnings lean on accruals. One year is noisy, growth and working-capital swings distort it, and this is operating cash, not free cash. Watch the multi-year trend.

How is the cash used?

  • No surplus to allocate
    What this means

    The business didn't generate positive Owner Earnings this year, so any distributions came from the balance sheet or borrowing, not from operations.

  • Investing or harvesting? 6.60×
    Expanding
    Capex $66M ÷ depreciation & amortization as filed $10M
    What this means

    Descriptive, not a grade. Above ~1× means investing faster than assets wear out (growth, or, sustained for years, today's earnings carrying less depreciation than tomorrow's will). Below means spending less than it's wearing out (efficiency, or a melting asset base). The ratio won't tell you which; the filings will.

The promise and the pay packet

  • Is the buyback buying ownership, or mopping up? 2.1%
    The count is genuinely shrinking
    Stock compensation $26M (fiscal 2025), 2.1% of revenue · repurchases $11M · diluted shares -7.9% since 2022
    What this means

    Stock handed to employees is a real cost paid in the owner's own currency: it is charged against profit, but the shares it creates are permanent. Many companies repurchase stock at the same time, which looks like a return of capital and often is not — if the count barely moves, the cash merely cancelled the pay packet and bought the owner nothing. The three states worth telling apart are a count genuinely shrinking, a count standing still despite large repurchases, and a count rising because the issuance was never offset at all.

Graham’s defensive tests · 0 of 3 met

Graham’s numerical criteria for the defensive investor (The Intelligent Investor, ch. 14), run on the filings. A floor of safety, not a buy signal; many fine modern businesses fail his strictest liquidity rules by design.

  • Adequate size Near
    Revenue ≥ $2B · $1.2B
    What this means

    Big enough to weather a storm. Graham's 1972 floor was ~$100M of sales (≈ $700M today); we use a $2B revenue line as a conservative modern stand-in.

  • Strong liquidity Miss
    Current ratio ≥ 2× · 0.71×
    What this means

    Current assets at least twice current liabilities, near-term bills covered without touching the business. Strict by design: many cash-rich modern firms run leaner and miss it, holding their cushion in longer-dated securities.

  • Conservative debt Miss
    Debt ≤ working capital · $319M vs ($262M) WC
    What this means

    Graham's rule that borrowings not exceed net current assets. Capital-heavy and buyback-heavy firms routinely fail it, read it next to interest coverage, not alone.

  • Moderate price
    P/E ≤ 15 and P/E × P/B ≤ 22.5 · decided by the price
    What this means

    Graham's valuation gate, the wall he kept between a sound business and a sound investment. Three-year average earnings are $0.26/share (latest year $1.78), the averaged base the calculator's gate runs on, and book value is $-0.83/share. Enter a price in “What the price implies” just below for the P/E, P/B, and whether it clears. But this is the rule Buffett outgrew: there's no hard P/E law, and a wonderful business can deserve a far richer multiple if the thesis holds, treat it as the bargain-hunter's floor, not a verdict on the price.

Durability & moat, 2022–2025

Whether the record’s returns held, and what the capital reinvested earned.

  • Profitable years 2 of 4
    What this means

    Lost money in 2 year(s), look at what happened there before trusting the average.

  • Operating margin −11% → 12% (2-yr avg ends)

    In the filing’s words The record and the words agree: the margin widened and the filing attributes the gain to its own pricing, not volume alone.

    What this means

    Through the cycle the operating margin widened — about −11% early to 12% lately, median −9% — pricing power intact or improving.

  • Reinvestment, incremental ROIC returns capital
    What this means

    The capital base barely grew: this business returns cash through dividends and buybacks rather than reinvesting. Judge it on the cash returned, not on compounding.

  • Worst year 2023 · −13.9% op. margin
    What this means

    Operations went underwater in 2023, understand why before trusting the good years.

  • Share count −2.7%/yr
    What this means

    The share count is shrinking, buybacks are quietly growing your slice of the business.

  • How management talks about it Promotional
    What this means

    The record is compounding, but the filing leans on a promoter’s vocabulary rather than the per-share, return-on-capital terms an owner uses. The results back the talk here; the register is still worth noting.

All figures as filed; the source filing is linked above.

Current Position

as of the latest quarter, Jun 30, 2026

Can the business pay what it owes this year, off the freshest balance sheet: the quality of the assets, the debt actually coming due, and what a low ratio means here.

Current assets$725M
  • Cash & short-term investments$222M
  • Receivables$271M
  • Inventory$150M
  • Other current assets$82M
Current liabilities$868M
  • Accounts payable$30M
  • Other current liabilities$838M
Current ratio0.84×all current assets ÷ what's due · Graham looked for 2×
Quick ratio0.66×stricter: inventory excluded
Cash ratio0.26×strictest: cash alone against what's due
Working capital($143M)the cushion left after near-term bills
Cash runway2.0 yrsthe business is consuming cash; this is how long the cash on hand lasts at that rate
Revenue, latest quarter vs. a year ago+13.6%the freshest read on whether the business is still growing
Current ratio, recent quarters0.9× → 0.8×
Deeper floors
Tangible book value($210M)equity stripped of goodwill & intangibles
Net current asset value($716M)Graham's net-net: current assets less all liabilities
Debt incl. operating leases$509M$22M of it operating leases

From the company's latest filing.

Management, ownership & pay

read the proxy →

From the proxy: how much of the business the people running it own, and how they are paid, beside what the business earned for its owners in the same years.

Fiscal yearChief executivePay, as filed“Actually paid”Owner earnings
2023Mark Crossley$4.4M−$5.5M($308M)
2024Mark Crossley$3.9M$1.2M$20M
2025Joe Ciaffoni$18.5M$63.3M($37M)
2025Mark Crossley$3.2M$19.3M($37M)

Both pay figures are the company’s own, from the pay-versus-performance table its proxy statement files. “As filed” is the Summary Compensation Table total: salary, bonus, and equity awards at their value on the day of grant. “Actually paid” is the SEC’s prescribed recalculation, which re-marks those equity awards to what they became as they vested; it can swing far above or below the filed figure in either direction, and negative years occur. Owner earnings are the whole business's, from the record above, for the same fiscal years.

  • Insider ownership<1%

    The stake all directors and executive officers hold together, per the 2026 proxy: skin in the game, the first thing Munger reads.

  • Stock-based compensation$26M

    The slice of the business handed to employees in shares in fiscal 2025, 2.1% of revenue, equal to 9.9% of operating profit. Buffett's oldest accounting fight: this is compensation, compensation is an expense, real whether or not the headline earnings admit it. One trap: the cash-flow statement adds SBC back, so the operating cash, and the owner earnings drawn from it, are flattered by exactly this amount; counted as the cost it is, what an owner keeps is lower.

Peers, Pharmaceuticals

The same industry, side by side on owner economics. Each column names the period it is read over, and a median resting on fewer than three years carries that count beside it; the group median at the foot is the line to read each figure against.

CompanyRevenuelatest FY, USDGross marginmedian over the recordOp. marginmedian over the recordROICmedian over the recordOwner earn. marginmedian over the record
ALKSAlkermes$1.5B84%-4.8%-7%3%
PAHCPhibro Animal Health Corporation$1.3B32%8.8%16%3%
LKFTLakefront Biotherapeutics$1.3B92%2y-37.1%-6%-106%
INDVIndivior Pharmaceuticals Inc.$1.2B82%-2.9%-2%
ENLVEnlivex Ltd.$1.2B-1.2%1y-62%-1%1y
PBHPrestige Consumer Healthcare$1.1B56%29.0%8%21%
ACADACADIA Pharmaceuticals Inc.$1.1B94%-43.2%-48%-26%
LEGNLegend Biotech Corporation$1.0B55%-198.6%-125%-143%
Group median82%-3.8%-1%
IV

The price

What a price has to assume.

What the price implies

reverse-DCF

Indivior Pharmaceuticals Inc. is profitable, but owner earnings are negative this year because capital spending currently outruns operating cash, a build-out, so the owner-earnings reverse-DCF has no positive base to grow. We read the price from both ends instead: type a price to see the steady-state profitability it demands, then set the mature margin you would believe and weigh the two against each other. Nothing leaves your browser unless you enter it in your notebook.

$
The assumptions

Revenue, delivered11%/yr’22→’25

Enter a price to run it.

Owner earnings it must reach
Margin the price demands
Owner-earnings margin today−8%

Two reads of one future. From your price: the owner earnings the company must reach, valued at a mature multiple and discounted back at your rate, expressed as the margin it implies on revenue grown at your rate. From your belief: the mature margin you would credit, set on the dial above. When the margin the price demands runs above the one you would believe, you are paying for a future taken on faith. For a deep cyclical at a trough, normalized through-cycle earnings are the better lens; this mode is for the genuinely unprofitable, and for the profitable business whose capital spending currently outruns its cash.

Cite: Owner Scorecard, "Indivior Pharmaceuticals Inc. (INDV), the owner's record," https://ownerscorecard.com/c/INDV, data as of 2026-08-17.

Manual order: ← INDI its page in the Manual INGM →

Industry order: ← INCR the Pharmaceuticals chapter INSM →